News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
461,121 Results
Type
Article (29405)
Company Profile (157)
Press Release (431559)
Section
Business (139778)
Career Advice (1574)
Deals (24070)
Drug Delivery (81)
Drug Development (49695)
Employer Resources (159)
FDA (10041)
Job Trends (10707)
News (226227)
Policy (18688)
Tag
2024 BioCapital Digital (3)
2024 BioForest Digital (3)
2024 BioForest Standard (1)
2024 BioMidwest Digital (3)
2024 BioMidwest Standard (2)
2024 Bio NC Digital (7)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (10)
2024 Biotech Beach Digital (5)
2024 Biotech Beach Standard (7)
2024 Genetown Standard (7)
2024 Lone Star Bio Digital (3)
2024 Pharm Country Digital (3)
2024 Pharm Country Standard (6)
2025 Lone Star Bio Digital (3)
2026 BioCapital Elite (1)
2026 BioMidwest Elite (2)
2026 Biotech Bay Elite (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Pharm Country Elite (1)
2026 Pharm Country Standard (1)
Academia (2059)
Academic (2)
Accelerated approval (1)
Adcomms (17)
Allergies (72)
Alliances (33276)
ALS (73)
Alzheimer's disease (944)
Antibody-drug conjugate (ADC) (71)
Approvals (10071)
Artificial intelligence (178)
Autoimmune disease (10)
Automation (10)
Bankruptcy (175)
Best Places to Work (8740)
BIOSECURE Act (12)
Biosimilars (68)
Biotechnology (106)
Bladder cancer (45)
Brain cancer (19)
Breast cancer (175)
Cancer (1310)
Cardiovascular disease (107)
Career advice (1366)
Career pathing (32)
CAR-T (100)
Cell therapy (284)
Cervical cancer (12)
Clinical research (40510)
Collaboration (560)
Compensation (282)
Complete response letters (13)
COVID-19 (1523)
CRISPR (24)
C-suite (174)
Cystic fibrosis (81)
Data (1442)
Decentralized trials (1)
Denatured (21)
Depression (27)
Diabetes (163)
Diagnostics (4362)
Digital health (9)
Diversity (7)
Diversity, equity & inclusion (40)
Drug discovery (81)
Drug pricing (62)
Drug shortages (6)
Duchenne muscular dystrophy (62)
Earnings (54111)
Editorial (14)
Employer branding (24)
Employer resources (138)
Events (73230)
Executive appointments (550)
FDA (10853)
Featured Employer (38)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (2)
Frontotemporal dementia (5)
Funding (545)
Gene editing (66)
Generative AI (16)
Gene therapy (208)
GLP-1 (453)
Government (2501)
Grass and pollen (2)
Guidances (33)
Healthcare (12822)
Huntington's disease (16)
IgA nephropathy (16)
Immunology and inflammation (50)
Indications (17)
Infectious disease (1613)
Inflammatory bowel disease (106)
Inflation Reduction Act (8)
Influenza (27)
Intellectual property (52)
Interviews (232)
IPO (11579)
IRA (23)
Job creations (2353)
Job search strategy (1198)
Kidney cancer (7)
Labor market (31)
Layoffs (252)
Leadership (14)
Legal (4230)
Liver cancer (48)
Lung cancer (181)
Lymphoma (98)
Machine learning (3)
Management (53)
Manufacturing (175)
MASH (40)
Medical device (8627)
Medtech (8632)
Mergers & acquisitions (12904)
Metabolic disorders (405)
Multiple sclerosis (47)
NASH (14)
Neurodegenerative disease (47)
Neuropsychiatric disorders (6)
Neuroscience (1297)
NextGen: Class of 2025 (4582)
Non-profit (3693)
Northern California (1783)
Now hiring (36)
Obesity (207)
Opinion (141)
Ovarian cancer (49)
Pain (53)
Pancreatic cancer (50)
Parkinson's disease (95)
Partnered (17)
Patents (103)
Patient recruitment (67)
Peanut (42)
People (44704)
Pharmaceutical (44)
Pharmacy benefit managers (5)
Phase I (11907)
Phase II (17662)
Phase III (14518)
Pipeline (783)
Podcasts (30)
Policy (62)
Postmarket research (1568)
Preclinical (5082)
Press Release (71)
Prostate cancer (67)
Psychedelics (20)
Radiopharmaceuticals (186)
Rare diseases (273)
Real estate (4215)
Recruiting (62)
Regulatory (13212)
Reports (49)
Research institute (1822)
Resumes & cover letters (213)
Rett syndrome (3)
RNA editing (1)
RSV (30)
Schizophrenia (51)
Series A (95)
Series B (63)
Service/supplier (9)
Sickle cell disease (41)
Southern California (1480)
Special edition (8)
Spinal muscular atrophy (110)
Sponsored (23)
Startups (2760)
State (2)
Stomach cancer (8)
Supply chain (30)
The Weekly (8)
United States (15188)
Vaccines (344)
Venture capitalists (30)
Webinars (11)
Weight loss (122)
Women's health (15)
Worklife (16)
Date
Today (170)
Last 7 days (520)
Last 30 days (2011)
Last 365 days (24489)
2025 (5951)
2024 (25679)
2023 (29315)
2022 (37231)
2021 (40834)
2020 (38205)
2019 (32388)
2018 (24295)
2017 (22279)
2016 (21359)
2015 (25028)
2014 (19126)
2013 (15447)
2012 (16562)
2011 (17130)
2010 (16317)
Location
Africa (573)
Alabama (33)
Alaska (7)
Arizona (134)
Arkansas (9)
Asia (24964)
Australia (4188)
California (3960)
Canada (1512)
China (276)
Colorado (163)
Connecticut (196)
Delaware (107)
Europe (59131)
Florida (609)
Georgia (142)
Hawaii (1)
Idaho (39)
Illinois (312)
India (21)
Indiana (273)
Iowa (6)
Japan (126)
Kansas (57)
Kentucky (18)
Louisiana (8)
Maine (48)
Maryland (524)
Massachusetts (3023)
Michigan (161)
Minnesota (258)
Mississippi (2)
Missouri (57)
Montana (27)
Nebraska (22)
Nevada (45)
New Hampshire (34)
New Jersey (1229)
New Mexico (23)
New York (1156)
North Carolina (745)
North Dakota (7)
Northern California (1783)
Ohio (145)
Oklahoma (11)
Oregon (21)
Pennsylvania (847)
Puerto Rico (9)
Rhode Island (21)
South America (784)
South Carolina (11)
Southern California (1480)
Tennessee (65)
Texas (547)
Utah (107)
Virginia (82)
Washington D.C. (44)
Washington State (308)
West Virginia (3)
Wisconsin (47)
461,121 Results for "anavex life sciences corp".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Anavex Life Sciences to Present at the 24th Annual Needham Virtual Healthcare Conference
April 1, 2025
·
3 min read
Press Releases
Anavex Life Sciences to Present at the 45th Annual TD Cowen Health Care Conference
February 24, 2025
·
3 min read
Pharm Country
Anavex Life Sciences Announces Expansion of Leadership Team
Anavex Life Sciences Corp. announced the addition and appointment of new senior team members with a track record of successfully bringing drugs to market.
May 22, 2024
·
6 min read
Press Releases
Anavex Life Sciences Reports Fiscal 2025 First Quarter Financial Results and Provides Business Update
February 12, 2025
·
7 min read
Pharm Country
Anavex Life Sciences to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference
Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL) today announced that Christopher U. Missling, PhD, President and Chief Executive Officer of Anavex, will present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference being held June 27, 2024.
June 20, 2024
·
3 min read
Press Releases
Anavex Life Sciences Announces Issuance of Blarcamesine (ANAVEX®2-73) Composition of Matter U.S. Patent Expanding its Intellectual Property Portfolio
January 27, 2025
·
5 min read
Press Releases
Anavex Life Sciences to Announce Fiscal 2025 First Quarter Financial Results on Wednesday, February 12, 2025
February 5, 2025
·
3 min read
Press Releases
Anavex Life Sciences to Present at the 43rd Annual J.P. Morgan Healthcare Conference
January 6, 2025
·
3 min read
Pharm Country
Anavex Life Sciences to Present at the 23rd Annual Needham Virtual Healthcare Conference
Anavex Life Sciences Corp. today announced that it will present at the 23rd Annual Needham Virtual Healthcare Conference.
March 25, 2024
·
3 min read
Business
Anavex Life Sciences to Announce Fiscal 2024 Second Quarter Financial Results on Thursday, May 9th, 2024
Anavex Life Sciences Corp. announced that it will issue financial results for its fiscal quarter ended March 31, 2024, on Thursday, May 9, 2024.
May 2, 2024
·
3 min read
1 of 46,113
Next
